More News

18 Dec 2019 Shandong Fontacea Announces License Agreement with Janssen to Develop and Commercialize Anti-IL17A Monoclonal Antibody
18 Dec 2019 Cerevance Enters Research Collaboration with Takeda to Advance New Treatments for Gastrointestinal Disorders
11 Dec 2019 GenEdit and Editas Medicine Enter into Exclusive License and Collaboration Agreement for Nanoparticle Gene Therapy Delivery
10 Dec 2019 AbbVie and Scripps Research announce collaboration to develop a broad range of new therapeutics
09 Dec 2019 Samyang Biopharm USA, Inc. and Talix Therapeutics NV Announce Global Strategic Collaboration to Advance Novel Immuno-Oncology Therapeutic
09 Dec 2019 Merck to Acquire ArQule, Advancing Leadership in Oncology
09 Dec 2019 Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion
09 Dec 2019 Healx Joins Forces with Boehringer Ingelheim to Discover New Treatment Approaches for Rare Neurological Diseases
08 Dec 2019 Denovo Biopharma Licenses Global Rights to a Novel Late-Stage Oncology Drug from Sunesis Pharmaceuticals
08 Dec 2019 Janssen to Acquire Investigational Bermekimab from XBiotech
06 Dec 2019 Cerecor to Acquire Aevi Genomic Medicine
04 Dec 2019 Gatehouse Bio collaborates with AstraZeneca to accelerate new drug discovery
03 Dec 2019 Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics
02 Dec 2019 Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy
02 Dec 2019 Samyang Biopharm USA, Inc and CanCure LLC Announce Global Strategic Collaboration to Advance Novel Immuno-Oncology Therapeutic
27 Nov 2019 Hoth Therapeutics and North Carolina State University Enter License Agreement for Gene Therapy
26 Nov 2019 Woolsey Pharmaceuticals Signs License Agreement With Asahi Kasei Pharma for Exclusive Rights to Fasudil
25 Nov 2019 Asahi Kasei Group Announces a Recommended Conditional Voluntary Public Offer for Veloxis
25 Nov 2019 Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death
21 Nov 2019 Vor Biopharma and MaxCyte Announce Clinical and Commercial License Agreement for Engineered Hematopoietic Stem Cells (eHSCs) to Treat Cancer
21 Nov 2019 ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational “bNAb” with potential for long-acting HIV treatment and prevention
21 Nov 2019 Harpoon Therapeutics and AbbVie Announce Licensing and Option Collaboration to Advance HPN217, Harpoon’s BCMA-Targeting TriTAC®, and Expand Existing Discovery Collaboration
21 Nov 2019 Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical
20 Nov 2019 Excelra Announces a Drug Repurposing Collaboration With Maruho On Dermatological Applications
20 Nov 2019 Dragonfly Therapeutics Announces Collaboration with AbbVie for Autoimmune Diseases and Oncology

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top